OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis
Diana I. Bocancea, Anna L. Svenningsson, Anna C. van Loenhoud, et al.
Brain (2023) Vol. 146, Iss. 9, pp. 3719-3734
Open Access | Times Cited: 24

Showing 24 citing articles:

Timing of lifespan influences on brain and cognition
Kristine B. Walhovd, Martin Lövdén, Anders M. Fjell
Trends in Cognitive Sciences (2023) Vol. 27, Iss. 10, pp. 901-915
Open Access | Times Cited: 59

Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Joseph Therriault, Suzanne E. Schindler, Gemma Salvadó, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 232-244
Closed Access | Times Cited: 58

Epilepsy and epileptiform activity in late-onset Alzheimer disease: clinical and pathophysiological advances, gaps and conundrums
Anita Kamondi, Madeleine Grigg‐Damberger, Wolfgang Löscher, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 3, pp. 162-182
Closed Access | Times Cited: 33

Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology
Sophie E Mastenbroek, Jacob W. Vogel, Lyduine E. Collij, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17

Neuroimaging Predictors of Cognitive Resilience against Alzheimer's Disease Pathology
McKenna E. Williams, Christine Fennema‐Notestine, Tyler Bell, et al.
Annals of Neurology (2025)
Open Access | Times Cited: 1

Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease
Gillian Coughlan, Hannah M Klinger, Rory Boyle, et al.
JAMA Neurology (2025)
Closed Access | Times Cited: 1

Sex-related differences in genetically determined Alzheimer’s disease
Laura del Hoyo Soriano, Olivia Wagemann, Alexandre Bejanin, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access | Times Cited: 1

Amyloid and Tau Pathology in Cognitively Unimpaired Individuals With a Parental History of Alzheimer Disease
Valentin Ourry, Alfonso Fajardo-Valdez, Jean‐Paul Soucy, et al.
Neurology (2025) Vol. 104, Iss. 9
Closed Access | Times Cited: 1

Plasma phosphorylated tau‐217 exhibits sex‐specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults
Rowan Saloner, Lawren VandeVrede, Breton M. Asken, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 1, pp. 376-387
Open Access | Times Cited: 17

Structural white matter properties and cognitive resilience to tau pathology
Ting Qiu, Zhen‐Qi Liu, François Rheault, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3364-3377
Open Access | Times Cited: 8

Tau‐neurodegeneration mismatch reveals vulnerability and resilience to comorbidities in Alzheimer's continuum
Xueying Lyu, Michael Tran Duong, Long Xie, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 3, pp. 1586-1600
Open Access | Times Cited: 11

Factors associated with age at tau pathology onset and time from tau onset to dementia
Margo B. Heston, Jordan P Teague, Karly Alex Cody, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Aging and cognitive resilience: Molecular mechanisms as new potential therapeutic targets
Ana Cordeiro, Catarina Gomes, Joana Bicker, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104093-104093
Open Access | Times Cited: 3

Alzheimer’s therapeutic development: shifting neurodegeneration to neuroregeneration
Miao‐Kun Sun, Daniel L. Alkon
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 3, pp. 197-209
Closed Access | Times Cited: 2

Biological mechanisms of resilience to tau pathology in Alzheimer’s disease
Anna L. Svenningsson, Diana I. Bocancea, Erik Stomrud, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2

Treating Alzheimer’s Disease: Focusing on Neurodegenerative Consequences
Miao‐Kun Sun, Daniel L. Alkon
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S263-S274
Closed Access | Times Cited: 2

Cognitive resilience in Alzheimer’s disease: from large-scale brain networks to synapses
Danilo Negro, Patricio Opazo
Brain Communications (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 4

Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology
Sophie E Mastenbroek, Jacob W. Vogel, Lyduine E. Collij, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Highlander

The Neuroscientist (2024) Vol. 30, Iss. 1, pp. 7-8
Closed Access

Rethinking the residual approach: Leveraging machine learning to operationalize cognitive resilience in Alzheimer’s disease
Colin Birkenbihl, Madison Cuppels, Rory Boyle, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Resistance and resilience to tau pathology in Alzheimer's disease: Effects of age, sex, and APOE alleles
Yury Loika, Stephanie Webster, Elena Loiko, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2024) Vol. 16, Iss. 4
Open Access

Page 1

Scroll to top